This annex contains a one-page table for each country which used the NDP indicators for assessing its national drug policy, namely Bulgaria, Chad, Colombia, Guinea, India, Mali, Philippines, Sri Lanka, Thailand, Viet Nam, Zambia and Zimbabwe.
Each page contains rated information on:
1. The achievement of the NDP in relation to the four objectives: availability of essential drugs, accessibility of essential drugs, quality of drugs, rational use of drugs.
2. The level of implementation of each key component of the NDP: legislation and regulation, essential drugs selection and drug registration, drug allocation in the health budget/public sector financing policy, public sector procurement procedures, public sector distribution and logistics, pricing policy, information and continuing education on drug use (structure and process).
The rating was done by the teams during the workshop on the basis of the data collected in each country. It used both calculation of averages and judgment related to the relative importance of the various indicators in each subgroup. It was refined later in DAP once new and more accurate data were sent by the countries (see Annex 6).
It should however be seen as tentative and is provided in this annex as an example of what can be achieved with the results of an indicator exercise